相关实验视频
Updated: Sep 11, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.0K
含葡萄糖与无葡萄糖透析剂用于维持血液透析的患者:多中心随机对照研究的研究方案-GLUMO研究
Zhifeng Zhou1, Qing Xu1, Xin He2
1Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, China.
PloS one
|August 11, 2025
概括
这项研究评估了将葡萄糖添加到透析液是否有利于接受维持血液透析 (HD) 的患者. 它比较含葡萄糖与无葡萄糖透析剂,以评估心血管事件和低血糖风险.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心血管医学 心血管医学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 无葡萄糖透析剂在中国和欧洲很常见,用于预防感染和控制脂质.
- 人们对无葡萄糖透析存在担忧,包括潜在的低血糖症,氨基酸损失和心血管风险.
- 将葡萄糖添加到透析剂中可能有助于在血液透析 (HD) 期间保持血糖水平.
研究的目的:
- 评估使用含有5.5mmol/L葡萄糖的透析剂在维持性疾病患者中的疗效和安全性.
- 为了比较含葡萄糖和无葡萄糖透析剂组之间的主要心血管和脑血管不良事件 (MACCE).
- 评估二次结局,包括死亡率,日内分析性低血压和低血糖症.
主要方法:
- 这是一项多中心,前性,随机对照试验 (RCT),涉及中国约600名维持性疾病患者.
- 参与者将被随机分配,以1:1的比例接受含葡萄糖或无葡萄糖透析剂.
- 主要结果是MACCE的发病率,通过盲目的结果评估和数据分析.
主要成果:
- 主要结局:主要心血管和脑血管不良事件 (MACCE) 的发生率.
- 二次结果:全因死亡率,日内分析性低血压 (IDH),低血糖,血压和葡萄糖变化,血管接入功能,心脏功能和疲劳.
- 数据分析将采用治疗意图或每个协议的方法.
结论:
- 这项研究将提供关于5.5mmol/L含葡萄糖透析剂对维持HD的疗效和安全性的证据.
- 结果将为未来的透析剂选择提供信息,并优化透析治疗方案.
- 这项研究旨在提高患者护理和血液透析环境中的结果.
相关概念视频
Hemodialysis III: Nursing Management
187
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
187
Hemodialysis I: Introduction
290
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
290
Hemodialysis II: Procedure and Complications
131
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
131
Glucose Homeostasis: Regulation of Blood Glucose
2.5K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.5K
Dialysis
478
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
478
Hypoglycemia and Glucagon
335
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
335

